Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Asynchrony in Executive Networks Predicts Cognitive Slowing in Multiple Sclerosis.
Neurophysiological Correlates of Central Fatigue in Healthy Subjects and Multiple Sclerosis Patients before and after Treatment with Amantadine.
Measures of aging with disability in U.S. secondary data sets: Results of a scoping review.
HIV immunodynamics and multiple sclerosis.
Preferences of Patients With Multiple Sclerosis for Attributes of Disease Modifying Drugs In Decision-Making: A Nominal Group Technique And Best-Worst Scaling.
The role of neurotrophins in multiple sclerosis-pathological and clinical implications.
Increased carbonylation, protein aggregation and apoptosis in the spinal cord of mice with experimental autoimmune encephalomyelitis.
Prevalence, demographics and clinical characteristics of multiple sclerosis in Qatar.
Differential screening-selected gene aberrative in neuroblastoma (DAN) is increased in the CSF of patients with MS and may be induced by therapy with interferon-β.
Immune-regulatory mechanisms of classical and experimental multiple sclerosis drugs: special focus on helminth-derived treatments.
Retinal degeneration in primary-progressive multiple sclerosis: A role for cortical lesions?
Type-I interferons suppress microglial production of the lymphoid chemokine, CXCL13.
High CD6 and low chemokine receptor expression on peripheral blood lymphocytes correlates with MRI gadolinium enhancement in MS.
Multicystic demyelinating myelopathy: Widening spectrum of pediatric aquaporin-4 autoimmunity.
Myelin Oligodendrocyte Glycoprotein (MOG35-55) Induced Experimental Autoimmune Encephalomyelitis (EAE) in C57BL/6 Mice.
[Th17/Treg unbalance is involved in the pathogenesis of experimental autoimmune encephalomyelitis].
[Pay attention to the differences and similarities in the pathogenesis and management of multiple sclerosis and neuromyelitis optica].
Acute hemorrhagic leukoencephalitis (Weston-Hurst syndrome) in a patient with relapse-remitting multiple sclerosis.
Efficacy of Intravenous Immunoglobulin in Neurological Diseases.
Multisystem involvement in neuromyelitis optica.
Decreased regenerative capacity of oligodendrocyte progenitor cells (NG2-glia) in the ageing brain: a vicious cycle of synaptic dysfunction, myelin loss and neuronal disruption?
Alerted microglia and the sympathetic nervous system: a novel form of microglia in the development of hypertension.
Sexual problems among women with multiple sclerosis.
Seropositive Neuromyelitis Optica: A Pediatric Case Report and 6-Year Follow-Up.
Multiple sclerosis treatment: risk mitigation.
Pages
« first
‹ previous
…
518
519
520
521
522
523
524
525
526
…
next ›
last »